ERCC1 and non-small cell lung carcinoma: Previous clinical studies have investigated the role of RRM1 and ERCC1 expression levels in the chemotherapy resistance among NSCLC.8-10 The present study suggests that high expression of RRM1 was associated with longer survival time and better response to chemotherapy when compared with low expression.